Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

How To Get Ahead In The Trendy World Of Immuno-Oncology

Executive Summary

With basic research in immuno-oncology still very limited, there are still a lot of opportunities to develop new breakthrough therapies beyond checkpoint inhibitors, companies active in the space said during a panel at the recent Biotech Showcase.

Advertisement

Related Content

Genentech, BioNTech Pact Aims To Make Targeted Cancer Vaccines
Amgen's Imlygic 1st FDA-Approved Oncolytic Virus Therapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register